New platform features advanced AI-powered insights for cardiovascular outcomes improvement.
CardioAccess today unveiled its next-generation analytics platform, featuring advanced artificial intelligence capabilities designed to help healthcare organizations identify at-risk patients and optimize treatment protocols.
The new platform includes predictive analytics, natural language processing for clinical notes, and automated quality measure calculation. Early adopters have reported significant improvements in their ability to identify care gaps and implement targeted interventions.
"Our new analytics platform represents a major leap forward in how healthcare organizations can leverage their data," said Michael Chen, CTO of CardioAccess. "We're putting the power of AI to work for clinicians and quality teams."
The new platform includes predictive analytics, natural language processing for clinical notes, and automated quality measure calculation. Early adopters have reported significant improvements in their ability to identify care gaps and implement targeted interventions.
"Our new analytics platform represents a major leap forward in how healthcare organizations can leverage their data," said Michael Chen, CTO of CardioAccess. "We're putting the power of AI to work for clinicians and quality teams."
About CardioAccess
CardioAccess is a leading provider of clinical outcomes software solutions for healthcare organizations. Our innovative platform helps hospitals and health systems track, measure, and improve cardiovascular patient outcomes. For more information, visit cardioaccess.com.
Media Contact
Media Relations, CardioAccess
info@cardioaccess.com
(954) 438-0885